References
- American Conference of Governmental Industrial Hygienists (ACGIH). Documentation of the thresholds limit values and biological exposure indices7th. ACGIH, Cincinnati 2001
- Perbellini L, Princivalle A, Caivano M, Montagnani R. Biological monitoring of occupational exposure to N, N-dimethylacetamide with identification of a new metabolite. Occup Environ Med 2003; 60: 746–775
- Kennedy GL. Biological effects of acetamide, formamide, and their mono and dimethyl derivatives: an update. Crit Rev Toxicol 2001; 31: 139–222
- Marino G, Anastopopoulos H, Woolf AD. Toxicity associated with severe inhalation and dermal exposure to dimethylacetamide and 1, 2-ethanediamine. J Occup Med 1994; 36: 637–641
- Su T-C, Lin P-H, Chiu M-J, Chu T-S, Chang MJW, Wang J-D, Cheng T-J. Dimethylacetamide, ethylenediamine, and diphenylmethane isocyanate poisoning manifest as acute psychosis and pulmonary edema: treatment with hemoperfusion. Clin Toxicol 2000; 38: 429–433
- Baum SL, Suruda AJ. Toxic hepatitis from dimethylacetamide. Int J Occup Environ Health 1997; 3: 1–4
- Spies GJ, Rhyne RH, Evans RA, Wetzel KE, Ragland DT, Turney HG, Leet TL, Oglesby JL. Monitoring acrylic fiber workers for liver toxicity and exposure to dimethylacetamide: 2. Serum clinical chemistry results of dimethylacetamide-exposed workers. J Occup Environ Med 1995; 37: 1102–1107
- Danan G, Benichou C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusion of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323–1330
- International Consensus Meetings. Criteria of drug-induced liver disorders. J Hepatol 1990; 11: 272–276
- Nomiyama T, Omae K, Ishizuka C, Yamaguchi T, Kawasumi Y, Yamada K, Endoh H, Sakurai H, et al. Dermal absorption of N, N‐dimethylacetamide in human volunteers. Int Arch Occup Environ Health 2000; 73: 121–126
- Kawai T, Mizunuma K, Okada Y, Odachi T, Horiguchi S, Iguchi H, Ikeda M. Separate determination by gas-chromatography of dimethylformamide, dimethylacetamide, monomethylformamide and monomethylacetamide in urine for biological monitoring. J Occup Health 1997; 39: 113–118
- Wang J-S, Groopman JD. Toxic liver disorders. Environmental occupational medicine3rd, WN Rom. Lippincott-Raven, PhiladelphiaUSA 1998; 831–841
- Zimmerman HJ. Classification of hepatotoxins and mechamisms of toxicity. Hepatotoxicity-the adverse effects of drugs and other chemicals on the liver2nd, HJ Zimmerman. Lippincott Williams and Wilkins, PhiladelphiaUSA 1999; 111–45
- Redlich CA, Beckett WS, Sparer A, Barwich KW, Riely CA, Miller H, Sigal SL, Shalat SL, Cullen MR. Liver disease associated with occupational exposure to the solvent dimethylformamide. Ann Intern Med 1988; 108: 680–686